UNSPSC 85892667: High dose rate (hdr) brachytherapy of mediastinum using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of mediastinum using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DB169CZ

UNSPSC 85892667 High dose rate (HDR) brachytherapy of mediastinum using californium 252 (Cf-252) is a Commodity code with minimal recent state and local procurement activity. The code's nominal scope—specialized nuclear medical therapy for mediastinal cancers—does not align with the single recent opportunity tagged under it, which is for temporary health professional staffing services across multiple clinical ancillary roles. The mismatch suggests either a cataloging error in the state or local procurement system or incidental tagging and does not reflect active demand for the therapy itself.

The County of Santa Clara Health System posted the only recent opportunity on July 7, 2026, as RFQ RFSQHHSFY270052, with proposals due October 7, 2026. The solicitation established a qualified vendor pool for temporary staffing in audiology, cardiology, diagnostic imaging, gastroenterology, health services assistance, medical social work, ophthalmology, orthopedics, patient transport, respiratory care, sterile processing, surgical/operating room services, and therapy—a non-exclusive, multiple-award vehicle with no guaranteed volume and a potential five-year qualified list duration. No geographic concentration or pattern of repeat issuers under this code is evident. Given the absence of opportunities aligned with the code's actual commodity definition and the single misaligned staffing solicitation, this code does not present an active procurement target for vendors in the specialized brachytherapy market at the state and local level.